Background: National stroke clinical quality registries/audits support improvements in stroke
care. In a 2016 systematic review, 28 registries were identified. Since 2016 there have been …

Background and objectives: Although the intravenous tissue plasminogen activator (rt-PA)
has been shown to be effective in the treatment of acute ischemic stroke (AIS), only a small …

Background/Objectives: Understanding the prognostic factors of acute ischemic stroke (AIS)
is essential for improving patient outcomes. The aim of this study was to establish the …

The cost-effectiveness of Cerebrolysin as an add-on therapy for moderate–severe acute
ischemic stroke is a topic that remains understudied. This study aims to address this gap by …

Background and objectives: In the era of personalized medicine, standard protocols
regarding the management of acute ischemic stroke (AIS) focus on time targets alone …

Background Wernicke-Korsakoff encephalopathy is a metabolic disease caused by vitamin
B1 deficiency that predominantly affects alcoholic patients. Its clinical picture is …

Background Globally, the majority of strokes affect people residing in lower-and lower-
middle-income countries (LMICs), but translating evidence-based knowledge into clinical …

Background and objectives: To minimize stroke-related deaths and maximize the likelihood
of cerebral reperfusion, medical professionals developed the “code stroke” emergency …

Abstract Introduction. The Registry of Stroke Care Quality (RES-Q) is used in Poland for
quality monitoring by numerous hospitals participating in the Angels Initiative. Our aim was …

Stroke is a major contributor to the global burden of disease. In 2017, stroke caused 691 age-
standardized disability-adjusted life years (DALYs) per 100,000 inhabitants in Europe …